Keywords
How to Cite
Abstract
According to the results of breast cancer data in the Republic of Uzbekistan in addition to the increase in morbidity and mortality from breast cancer among women the presence of age specific features among indigenous women in the direction of “rejuvenating” of the disease with all molecular-biological (phenotypic) subtypes of breast cancer were marked. Within the framework of age-related features the prevalence of the least favorable phenotypes of breast cancer was found among indigenous women: Her2/neu hyperexpressive and three times negative subtype of breast cancer. The data obtained made it possible to build a so-called population “portrait” of breast cancer on the territory of the Republic, which in turn would contribute to further improvement of cancer care for the female population of the country.References
Жукова Л.Г. Рак молочной железы с тройным негативным фенотипом у российской популяции больных. Клинико-морфологические особенности // Вопр.онкол. - 2015. - № 2. -Т. 61. - С. 189-194.
Кампова-Полевая Е.Б., Портной С.М. Актуальные аспекты клинической маммологии. - Москва: Авторская академия, 2014.
Поддубная И.В., Колядина И.В., Калашников Н.Д. и соавт. Популяционный «портрет» рака молочной железы в России: анализ данных российского регистра// Совр. Онкол. - 2015. - Т. 1. - № 1. - С. 25- 29.
Семиглазов В.Ф. Рак молочной железы: клинико-экспериментальные исследования // Вопр.онкол. -2016. - Т. 62. - № 2. - С. 208-213.
Статистика злокачественных новообразований 2014г. // Евраз.онкол. журн. - 2016. - Т. 4. - № 4. - С. 874- 879.
Худайкулов А.Т., Худайкулов Т.К. Компонентный анализ динамики заболеваемости раком молочной железы населения Узбекистана // Онкология. - 2016. - Т. 1. - № 1. - С. 34-37.
Atchley D.P., Albarracin C.T., Lopez A. et al. Clinical and pathologic characteristics of patients with BRCA- positive and BRCA- negative breast cancer // J. Clin. Oncol. - 2008. - Vol. 26. - P. 5367-5374.
Coleman M.P., Quaresma M., Berrito F. et al. Cancer survival in five continents: a worldwide population-based study (CONCORD) // Lancet Oncol. - 2008. - Vol. 9. - P. 730- 756.
Gonzalez-Angulo A.M., Timms K.M., Liu S. et al. Incidence and outcome of BRCA mutations in unselected patients with triple receptor- negative breast cancer // Clin. Cancer Res. - 2011. - Vol. 17. - P. 1082- 1089.
Mithin Vinod Shan, Anne E. Wiktor, Reid G. Meyer, et al. Change in Pattern oh HER2 Fluorescent in Situ Hybridizatione (FISH) Results in Breast Cancer Submitted for FISH Testing: Experience of a Reference Laboratory Using US Food and Drug Administration Criteria and American Society of Clinical Oncology and College of American Pathologists Guidelines // http: // jco.ascopubs.org/cgi/ doi/10.1200/Jœ.2015.61.8983
Perou C.M., Sorlie T., Eisen M.B. et al. Molecular portraits of human breast tumors // Nature. - 2000. - Vol. 406 (6797). - P. 747-752. - PMID: 10963602. DOI: 10.1038/35021093
Shan S.S., Ketterling R.P., Goets M.P., et al. Impact of American Pathologists guideline recommendation on HER2 interpretation in breast cancer // Hum.Path. -2010. - Vol. 41. - P. 103-106.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
© АННМО «Вопросы онкологии», Copyright (c) 2018